Once-Daily pill may ease transplant Patients' drug side effects
NCT ID NCT03979365
Summary
This study tested whether taking a once-daily, extended-release version of the anti-rejection drug tacrolimus causes fewer side effects and is easier to stick with than the standard twice-daily version. Researchers enrolled 261 adult kidney transplant recipients to compare symptoms like trembling hands, muscle cramps, and fatigue, as well as overall quality of life and medication adherence. The goal was to see if a simpler dosing schedule improves daily life for people who must take these medications long-term.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KIDNEY TRANSPLANT RECIPIENTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic Arizona
Phoenix, Arizona, 85054, United States
-
Mayo Clinic Florida
Jacksonville, Florida, 32224, United States
-
Mayo Clinic Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.